
TY  - JOUR
TI  - ICIEM Abstracts
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 36
IS  - S2
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-013-9633-z
DO  - doi:10.1007/s10545-013-9633-z
SP  - 91
EP  - 342
PY  - 2013
ER  - 

TY  - JOUR
TI  - Clinical Pharmacology Abstracts to be Presented at the Twenty-Seventh Annual Meeting of the American College of Clinical Pharmacology
JO  - The Journal of Clinical Pharmacology
VL  - 38
IS  - 9
SN  - 0091-2700
UR  - https://doi.org/10.1177/009127009803800901
DO  - doi:10.1177/009127009803800901
SP  - 842
EP  - 886
PY  - 1998
ER  - 

TY  - JOUR
TI  - E-Posters, EP3
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG
VL  - 120
IS  - s1
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.12295
DO  - doi:10.1111/1471-0528.12295
SP  - 232
EP  - 286
PY  - 2013
ER  - 

TY  - JOUR
TI  - P05. Posters 5
JO  - Australasian Journal of Dermatology
VL  - 38
IS  - S2
SN  - 0004-8380
UR  - https://doi.org/10.1111/ajd.1997.38.s2.261
DO  - doi:10.1111/ajd.1997.38.s2.261
SP  - 261
EP  - 291
PY  - 1997
ER  - 

TY  - JOUR
AU  - Baghaei, Kaveh
AU  - Tokhanbigli, Samaneh
AU  - Asadzadeh, Hamid
AU  - Nmaki, Saeed
AU  - Reza Zali, Mohammad
AU  - Hashemi, Seyed Mahmoud
TI  - Exosomes as a novel cell-free therapeutic approach in gastrointestinal diseases
JO  - Journal of Cellular Physiology
JA  - J Cell Physiol
VL  - 234
IS  - 7
SN  - 0021-9541
UR  - https://doi.org/10.1002/jcp.27934
DO  - doi:10.1002/jcp.27934
SP  - 9910
EP  - 9926
KW  - extracellular vesicles
KW  - gastrointestinal diseases
KW  - immune cell-derived exosomes
KW  - stem cell-derived exosomes
PY  - 2019
AB  - Abstract Cell communication through extracellular vesicles (EVs) has been defined for many years and it is not limited only to neighboring cells, but also distant ones in organisms receive these signals. These vesicles are secreted from the variety of cells and are composed of a distinctive component such as proteins, lipids, and nucleic acids. EVs have different classified subgroups regarding their cell origin, in this context, exosomes are the most appealing particles in cell biology, especially clinical in recent years and are represented as novel therapeutic agents with numerous advantages alongside and/or over cell therapy. However, cell therapy had a hopeful outcome in gastrointestinal diseases which have minimal alternatives in their treatments. Inflammatory bowel disease (IBD), liver fibrosis, gastrointestinal cancers are the examples that cell therapy and immunotherapy were applied in their treatment, therefore, the cell products like exosomes are the beneficial option in their treatment even cancers with promising results in animal models. In this review, we consider the main defined biogenesis, function, and component of secreted exosomes in different cells with a specific focus on the potential application of these exosomes as a cell-free therapeutic approach in gastrointestinal diseases like IBD, gastric cancer, and colon cancer. Additionally, exosomes role as therapeutic reagents mainly mesenchymal stem cells and dendritic cell-derived exosomes in different studies have been under intense investigation and even they are being studied in different clinical trials. Therefore, all these striking functions described for secretome implies the importance of these biocarriers.
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Acta Ophthalmologica Scandinavica
VL  - 84
IS  - s239
SN  - 1395-3907
UR  - https://doi.org/10.1111/j.1600-0420.2006.00812.x
DO  - doi:10.1111/j.1600-0420.2006.00812.x
SP  - 13
EP  - 72
PY  - 2006
ER  - 

TY  - JOUR
TI  - First Joint Meeting of The Wound Healing Society and the European Tissue Repair Society
JO  - Wound Repair and Regeneration
JA  - Wound Repair and Regeneration
VL  - 1
IS  - 2
SN  - 1067-1927
UR  - https://doi.org/10.1046/j.1524-475X.1993.10208.x
DO  - doi:10.1046/j.1524-475X.1993.10208.x
SP  - 84
EP  - 84
PY  - 1993
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 11th Annual ACVIM Forum: 1993 AMERICAN COLLEGE OF VETERINARY INTERNAL MEDICINE
JO  - Journal of Veterinary Internal Medicine
VL  - 7
IS  - 2
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1993.tb03179.x
DO  - doi:10.1111/j.1939-1676.1993.tb03179.x
SP  - 107
EP  - 151
PY  - 1993
ER  - 

TY  - JOUR
TI  - 2019 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 33
IS  - 5
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.15597
DO  - doi:10.1111/jvim.15597
SP  - 2375
EP  - 2547
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Views
JO  - Cytopathology
JA  - Cytopathology
VL  - 25
IS  - s1
SN  - 0956-5507
UR  - https://doi.org/10.1111/cyt.12182
DO  - doi:10.1111/cyt.12182
SP  - 22
EP  - 78
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 3
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 21
IS  - S15
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.21248
DO  - doi:10.1002/mds.21248
SP  - S517
EP  - S613
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstract of Paper to be Presented at American Association of Blood Banks: 42 Annual Meeting October 21â€“26, 1989
JO  - Transfusion
VL  - 29
IS  - S7
SN  - 0041-1132
UR  - https://doi.org/10.1046/j.1537-2995.29.7s.1.x
DO  - doi:10.1046/j.1537-2995.29.7s.1.x
SP  - 4S
EP  - 88S
PY  - 1989
ER  - 

TY  - JOUR
TI  - 21st Annual Meeting of the American Society for Photobiology
JO  - Photochemistry and Photobiology
VL  - 57
IS  - 6
SN  - 0031-8655
UR  - https://doi.org/10.1111/j.1751-1097.1993.tb09234.x
DO  - doi:10.1111/j.1751-1097.1993.tb09234.x
SP  - 1S
EP  - 110S
PY  - 1993
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 17
IS  - 2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.1993.tb00792.x
DO  - doi:10.1111/j.1530-0277.1993.tb00792.x
SP  - 442
EP  - 518
PY  - 1993
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Nephrology
VL  - 15
IS  - s3
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2010.01337.x
DO  - doi:10.1111/j.1440-1797.2010.01337.x
SP  - 62
EP  - 144
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Session C
JO  - Pediatric Transplantation
JA  - Pediatr Transplantation
VL  - 19
IS  - S1
SN  - 1397-3142
UR  - https://doi.org/10.1111/petr.12517
DO  - doi:10.1111/petr.12517
SP  - 135
EP  - 152
PY  - 2015
ER  - 

AU  - Kapoor, Rakesh
AU  - Nair, Harikumar
C7  - pp. 1-45
TI  - Gamma Linolenic Acid: Sources and Functions
SN  - 9780471384601
UR  - https://doi.org/10.1002/047167849X.bio026.pub2
DO  - doi:10.1002/047167849X.bio026.pub2
SP  - 1-45
KW  - GLA (gamma linolenic acid)
KW  - sources
KW  - metabolism
KW  - clinical trials
KW  - anti-inflammatory
KW  - cancer
KW  - arthritis
KW  - diabetes
KW  - essential fatty acid
KW  - borage
KW  - evening primrose
KW  - structured lipids
KW  - hemp
KW  - black currant
PY  - 2015
AB  - Abstract Gamma-linolenic acid (GLA, cis 6, cis 9, cis 12-octadecatrienoic acid) is a conditionally essential fatty acid of the n-6 family. It is produced in the mammalian body from enzymatic desaturation of linoleic acid, an essential fatty acid that must be supplied by the diet. It is widely distributed in plant kingdom in trace amounts, and is not present in major commercial vegetable seed oils. It is present in seeds of many species belonging to families Aceraceae, Boraginaceae, Cannabinaceae, Liliaceae, Onagraceae, Ranunculaceae, Saxifragaceae, and Scrophulariaceae. A very limited number of plant sources have been commercialized in last 30 years as a source of GLA, mainly in the health food industry and to a limited extent in pharmaceutical, pet food, and cosmetic industries. These include oils of borage, black currant, evening primrose, and recently hemp. The total market for GLA-containing oils is about $60?$70 million per year. Research on GLA in last three decades has focused on the physiological and pharmacological effects, including its effects on second messenger system in the body. On the production side, research focus is on identification of new sources and yield optimization. This article reviews the current state of knowledge about sources, and nutritional and health benefits of GLA and attempts to identify areas for future research that will help develop markets for GLA.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
VL  - 12
IS  - s15
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1399-5448.2011.01818.x
DO  - doi:10.1111/j.1399-5448.2011.01818.x
SP  - 40
EP  - 143
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Communications
JO  - Journal of the European Academy of Dermatology and Venereology
JA  - J Eur Acad Dermatol Venereol
VL  - 30
IS  - S6
SN  - 9780471384601
UR  - https://doi.org/10.1111/jdv.01_13709
DO  - doi:10.1111/jdv.01_13709
SP  - 26
EP  - 105
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts from the 24th Annual Scientific Meeting
JO  - Immunology & Cell Biology
JA  - Immunol Cell Biol
VL  - 84
IS  - 3
SN  - 9780471384601
UR  - https://doi.org/10.1111/j.1440-1711.2006.01450.x
DO  - doi:10.1111/j.1440-1711.2006.01450.x
SP  - A1
EP  - A34
PY  - 2006
ER  - 
